CDK Global has successfully renewed its DMS agreement with Sonic Automotive, securing a key partnership following two ...

In Hybrids amidst financial challenges. Read More CDK Global extends DMS contract with Sonic Automotive amid cyberattack ...

The news reinforces CDK's reputation in the DMS business and, presumably, will help the company land more extensions and new ...

It hasn’t been the best of years for CDK Global, but it got some good news Monday. Sonic Automotive, one of the nation’s ...

The contract extension with Sonic is a win for market leader CDK, which faced challenges over the summer after two ...

CDK, the leading automotive retail software provider, today announced the extension of its agreement with Sonic Automotive, ...

Coca-Cola is discontinuing the production of its new Spiced flavor just six months after the soda hit shelves, marking the ...

CDK2 inhibitors have received some attention at the 2024 ESMO Congress, with one candidate, PF-07104091, showing combination potential with CDK4-selective blockade in HR–positive, HER2–negative breast ...

Jessica Fye, an analyst from J.P. Morgan, has initiated a new Hold rating on Incyte (INCY). Jessica Fye has given her Hold rating due to a combination of factors regarding Incyte’s stock ...

New antitumor response data from a range of doses and regimens unveiled today at Incyte investor event These results build upon safety and tolerability data presented earlier today during a mini-oral ...

New antitumor response data from a range of doses and regimens unveiled today at Incyte investor event These results build upon safety and tolerability data presented earlier today during a mini ...

Incyte (Nasdaq:INCY) today announced new early clinical data for INCB123667, a highly selective, potential first-in-class CDK2 inhibitor, in patients with advanced solid tumors. The trial results ...